Orum Therapeutics, Inc. (KOSDAQ:475830)

Orum Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	113,103	4,065	19,700	126,658	11,276
Short-Term Investments	152,217	128,537	99,099	-	-
Trading Asset Securities	8,910	-	-	-	809.55
Cash & Short-Term Investments	274,230	132,602	118,799	126,658	12,085
Cash Growth	73.07%	11.62%	-6.21%	948.05%	-
Accounts Receivable	-	0.56	2.48	0.6	-
Other Receivables	797.82	380.84	2,530	492.53	38.37
Receivables	797.82	381.4	2,532	493.14	38.37
Prepaid Expenses	728.28	715.19	966.55	254.5	460.26
Other Current Assets	1,098	674.09	212.88	41.83	72.42
Total Current Assets	276,854	134,372	122,510	127,448	12,656
Property, Plant & Equipment	31,801	31,014	30,610	32,370	5,184
Long-Term Investments	45.41	43.05	44.1	12.87	2,552
Long-Term Deferred Tax Assets	2,921	2,769	597.08	974.69	543.48
Other Long-Term Assets	1,201	1,126	74.48	977.7	346.91
Total Assets	312,821	169,325	153,836	161,783	21,283

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	-	-	-	3.45	839.48
Accrued Expenses	5,154	4,056	2,079	5,138	4,932
Short-Term Debt	-	-	-	-	208.32
Current Portion of Leases	2,935	2,776	28,122	2,572	845.64
Current Income Taxes Payable	-	-	-	217.72	462.26
Other Current Liabilities	7,387	8,777	1,663	1,207	1,633
Total Current Liabilities	15,475	15,608	31,864	9,137	8,920
Long-Term Debt	-	-	-	-	937.44
Long-Term Leases	23,679	22,723	207.75	23,308	597.78
Other Long-Term Liabilities	185.14	105.47	0	138.26	136.6
Total Liabilities	39,339	38,437	32,071	32,583	10,592

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	2,123	2,123	1,843	460	115
Additional Paid-In Capital	100,366	100,366	179,471	690	1,035
Retained Earnings	2,940	18,218	-69,813	-64,072	-132,290
Comprehensive Income & Other	14,143	10,181	10,263	6,743	3,678
Total Common Equity	119,572	130,888	121,765	-56,180	-127,461
Shareholders' Equity	273,482	130,888	121,765	129,200	10,691
Total Liabilities & Equity	312,821	169,325	153,836	161,783	21,283

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	26,614	25,498	28,330	25,879	2,589
Net Cash (Debt)	247,616	107,103	90,469	100,779	9,496
Net Cash Growth	87.94%	18.39%	-10.23%	961.28%	-
Net Cash Per Share	11522.38	5146.28	6682.58	6693.64	2064.33
Filing Date Shares Outstanding	21.23	21.23	18.43	4.6	1.15
Total Common Shares Outstanding	21.23	21.23	18.43	4.6	1.15
Working Capital	261,378	118,764	90,647	118,310	3,736
Book Value Per Share	5631.61	6164.55	6607.19	-12212.99	-110835.99
Tangible Book Value	119,572	130,888	121,765	-56,180	-127,461
Tangible Book Value Per Share	5631.61	6164.55	6607.19	-12212.99	-110835.99
Land	-	-	-	-	1,591
Machinery	5,884	5,388	1,497	1,396	1,406
Construction In Progress	-	250	36	-	445.16

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error